Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    7 0 0 0

Joint Bone Spine
Volume 71, n° 6
pages 511-517 (novembre 2004)
Doi : 10.1016/j.jbspin.2004.04.007
Received : 26 Mars 2004 ;  accepted : 29 April 2004
Novel concepts and treatments for autoimmune disease: ten focal points

Jean Sibilia
Service de Rhumatologie - CHU Hautepierre Université Louis Pasteur 1, avenue Molière 67098 Strasbourg cedex, France 


Understanding the development of autoimmunity is a crucial step toward improving the management, not only of autoimmune diseases, but also of tumors and primary immunodeficiency syndromes. The rapid expansion of knowledge on autoimmunity is fueling the development of a novel approach known as targeted immunotherapy. The present review will concentrate on ten areas where major advances have been achieved:

early regulation of B-cell mediated autoimmunity;
thymic regulation of tolerance to tissue-restricted antigens via the transcription factor AIRE;
role for a population of regulatory T cells (CD4+ CD25+ Tregs) with unique effects;
major role for dendritic cells in the development of autoimmunity in conditions such as lupus;
role for T cells in autoimmune diseases;
role for T cells in rheumatoid arthritis, with new data from a murine model of spontaneous arthritis related to a ZAP-70 mutation;
role for the environment via innate immunity, in particular mediated by the toll-like receptors (TLR);
identification of new autoantigens with the description of sense-antisense peptides (e.g., proteinase 3-complementary proteinase 3);
the immunosenescence concept, which suggests that some autoimmune diseases may be related to premature aging of the immune system;
identification of new immunotherapy targets, including costimulation pathway molecules (CD28, CTLA4), original activation systems (BAFF/BLyS), and receptors such as TLRs.
These exciting insights into the pathogenic mechanisms underlying immune dysfunction will play a key role in advancing the field of immunorheumatology.

The full text of this article is available in PDF format.

Keywords : Autoimmunity, Tolerance, Lymphocytes, Autoimmune diseases, Innate immunity

© 2004  Elsevier SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline